Abstract
In this article, we present two accounts of intersubjectivity in Jaspers and Husserl, respectively. We argue that both can be brought together for a more satisfying account of empathy and communication in the context of psychiatric praxis. But while we restrict ourselves for the most part to this praxis, we also indicate the larger agenda that drives Jaspers and Husserl, despite all disagreement. Here we spell out, in particular, how a phenomenologically inspired account of empathy and intersubjectivity can have larger ramifications for a theory of social life and interaction. Finally, we argue for a ‘relaxed' view concerning the relation between pure and applied phenomenology, such that both can mutually benefit from one another.
References
1.
Schlimme JE, Schwartz MA: Recovery as regaining social cover? A phenomenological investigation about being in recovery from schizophrenia. Psychopathology 2013;46:102-110.
2.
Jaspers K: Vernunft und Existenz, ed 4. München/Zürich, Piper, 1935/1987.
3.
Jaspers K: Grundfragen der Philosophie (12 radio lectures from 1949); in Was ist Philosophie? München, Deutscher Taschenbuch Verlag, 1976, pp 33-120.
4.
Jaspers K: Allgemeine Psychopathologie, ed 4, 9, unaltered. Heidelberg, Springer, 1946/1973.
5.
Rinofner-Kreidl S: Zur Idee des Methodenpartikularismus in Jaspers' Allgemeiner Psychopathologie; in Rinofner-Kreidl S, Wiltsche HA (eds): Karl Jaspers' Allgemeine Psychopathologie zwischen Wissenschaft, Philosophie und Praxis. Würzburg, Königshausen & Neumann, 2008, pp 75-94.
6.
Jaspers K: Philosophie. München/Zürich, Piper, 1932/1994, vol 3.
7.
Jaspers K: Von der Wahrheit. München, Piper, 1947.
8.
Rabanus C: Karl Jaspers und die Kommunikation; in Yousefi HR, Schüssler W, Schulz R, Diehl U (eds): Karl Jaspers. Grundbegriffe seines Denkens. Reinbek, Lau, 2011, pp 83-96.
9.
Baeyer W, Ritter V: Der Begriff der Begegnung in der Psychiatrie. Nervenarzt 1955;26:369-376.
10.
Bouricius JK: Negative symptoms and emotions in schizophrenia. Schizophr Bull 1989;15:201-208.
11.
Berenbaum H, Oltmanns TF: Emotional experience and expression in schizophrenia and depression. J Abnorm Psychol 1992;101:37-44.
12.
Schlimme JE, Paprotny T, Brückner B: Karl Jaspers. Aufgaben und Grenzen der Psychotherapie. Nervenarzt 2012;83:84-91.
13.
Schlimme JE: Karl Jaspers' concept of existential psychotherapy; in Stanghellini G, Fuchs T (eds): One Century of Karl Jaspers' General Psychopathology. Oxford, Oxford University Press, 2013, in press.
14.
Jaspers K: Gesammelte Schriften zur Psychopathologie. Heidelberg, Springer, 1963.
15.
Stanghellini G: The ethics of incomprehensibility; in Stanghellini G, Fuchs T (eds): One Century of Karl Jaspers' General Psychopathology. Oxford, Oxford University Press, 2013, in press.
16.
Zahavi D: Intersubjectivity; in Luft S, Overgaard S (eds): The Routledge Companion to Phenomenology. London, Routledge, 2011, pp 180-189.
17.
Zahavi D: Husserl und die transzendentale Intersubjektvität. Heidelberg, Springer, 1996.
18.
Husserl E: Zur Phänomenologie der Intersubjektivität. Texte aus dem Nachlass. Dritter Teil (1929-1935) (Husserliana XV). Den Haag, Kluwer, 1973.
19.
Jaspers K: Allgemeine Psychopathologie, ed 1. Heidelberg, Springer, 1913.
20.
Schwartz MA, Wiggins OP: The phenomenology of schizophrenic delusions; in Spitzer M, Uehlein FA, Schwartz MA, Mundt C (eds): Phenomenology, Language, and Schizophrenia. Heidelberg, Springer, 1992, pp 305-319.
21.
Vongehr T: Am Bodensee 1923. Husserl und die Psychiatrie. Husserl trifft Ludwig Binswanger und Aby Warburg. Mitteilungsblatt für die Freunde des Husserl-Archivs (Husserl-Archief Leuven) 2010;33:11-16.
22.
Emrich HM, Schlimme JE: Wider das Gestell des Psychologischen. Heidegger in Psychiatrie, Psychotherapie und Psychoanalyse; in Thomä D (ed): Heidegger-Handbuch. Leben - Werk - Wirkung, ed 2. Stuttgart, Metzler, 2013, in press.
23.
Schlimme JE: Einleitung zu Der Mensch in der Psychiatrie von Ludwig Binswanger (1956); in Fuchs T, Heinze M, Kupke C, Schlimme JE (eds): Klassische Texte zur Philosophie und Psychiatrie des 20. Jahrhunderts. Stuttgart, Kohlhammer, 2013, in press.
24.
Gallagher S, Zahavi D: The Phenomenological Mind, ed 2. London, Routledge, 2012.
25.
Rümke HC, Neeleman J: The nuclear symptom of schizophrenia and the praecoxfeeling. Hist Psychiatry 1990;1:331-341.
26.
Heimann H, Spoerri T: Das Ausdrucksverhalten der mimischen Desintegratio bei chronischen Schizophrenen. Schweiz Med Wochenschr 1957;35/36:1126-1132.
27.
Wolf K, Köppel S, Mass R, Naber D: Identifizierung möglicher Kennparameter der ‘mimischen Desintegration' bei schizophrenen Patienten mittels einer Gesichts-EMG-Methode. Nervenarzt 2005;76:1103-1108.
28.
Penn DL, Sanna LJ, Roberts DL: Social cognition in schizophrenia: an overview. Schizophr Bull 2008;34:408-411.
29.
Couture SM, Penn DL, Roberts DL: The functional significance of social cognition in schizophrenia: a review. Schizophr Bull 2006;31:S44-S63.
30.
Luft S: Zur phänomenologischen Methode in Karl Jaspers' Allgemeine Psychopathologie; in Rinofner-Kreidl S, Wiltsche HA (eds): Karl Jaspers' Allgemeine Psychopathologie zwischen Wissenschaft, Philosophie und Praxis. Würzburg, Königshausen & Neumann, 2008, pp 31-51.
31.
Melle U: Edmund Husserl: from reason to love; in Drummond J, Embree L (eds): Phenomenological Approaches to Moral Philosophy. Dordrecht, Kluwer, 2002, pp 229-248.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
